We assist management companies, institutional investors, and sponsors in the creation and lifecycle of their investment funds, both in France and internationally. From structuring to fundraising, from regulatory approval to vehicle operations, our team designs tailored solutions for every strategy.

Our Private Funds team, formed in 2026 around Nicolas Capelli and Morgan Toanen, brings together all the expertise required for investment fund structuring in an integrated fund/tax offering, serving a French and international clientele.

We assist management companies in the structuring and fundraising of private equity, venture capital, mezzanine, private debt, infrastructure, and real estate (hospitality, value-add, and core) funds, as well as in executing secondary transactions (LP-led and GP-led). We also advise French and international institutional investors and family offices.

The team has recognized expertise in structuring semi-liquid funds—notably FCPR and ELTIF—intended for retail clients via unit-linked products in French and Luxembourg life insurance policies.

On the tax front, we advise on the tax structuring of alternative investment funds, including the implementation of carried interest and co-investment mechanisms, in an international environment where tax issues are central to our clients’ decisions.

We also support venture capital funds in their own fundraising efforts, working closely with the firm’s Corporate/M&A and Venture Capital teams.

Our expertises

  1. Private funds

Real Estate

Office repositioning, growth of operated assets (hospitality, managed residences, healthcare, logistics), energy and environmental performance requirements, rising interest rates and financing selectivity: real estate is undergoing a profound transformation. Institutional investors, funds, real estate companies, developers, end-users, and operators need advice that secures their transactions within a constantly evolving legal and tax framework.

Financial institutions & Insurance

Banks, insurers, mutual funds, management companies, intermediaries, and payment institutions operate under increasingly demanding supervision: anti-money laundering and terrorist financing, digital operational resilience, sustainable finance, customer protection, and product distribution, under the control of the ACPR, the AMF, and European authorities. At the same time, they continue their growth, refinancing, and restructuring operations.

FinTech

Payments, neobanks, embedded finance, crypto-assets, crowdfunding, regtech, insurtech: fintechs are transforming the financial industry, often faster than the law. Status, authorization, compliance, and financing must be considered together. Their development takes place within a European framework currently undergoing major restructuring (PSD2 and PSD3, MiCA, DORA, anti-money laundering regulation, AI regulation), under the supervision of the ACPR, the AMF, and the CNIL.

Technology

Artificial intelligence, quantum technologies, semiconductors, software, platforms, cybersecurity: Tech has become the driver of economic transformation and an issue of sovereignty. Start-ups, scale-ups, publishers, manufacturers, and investors operate at a sustained pace within a developing European framework (GDPR, AI Act, Data Act, DSA and DMA, NIS 2) where intellectual property, data, and compliance determine value creation.

Energy & Energy Transition

The energy transition is profoundly transforming the industrial and financial landscape: renewables, hydrogen and storage, the nuclear revival, electrification of uses, industrial decarbonization, and building energy sobriety. Industry players are operating within a constantly evolving regulatory framework at the crossroads of energy law, environmental law, public procurement, and financing.

Infrastructure

Transport, mobility, water, waste, digital and social infrastructure: infrastructure is at the heart of public policies on ecological transition, sovereignty, and regional planning. Its development mobilizes growing private capital, within increasingly sophisticated contractual and financial arrangements, under the watchful eye of demanding granting authorities, regulators, and local communities.

Healthcare and Life sciences

Pharmaceutical and medical biology laboratories, biotechs, medical devices, research and bioproduction suppliers, digital health, health product distribution: the sector combines active consolidation, innovation funding driven by specialized funds, and a demanding regulatory framework. Bioproduction technology acquisitions, biotech fundraising, laboratory consolidations, minority private equity investments: these transactions require a thorough understanding of the sector's specificities.

Accolades

Jeantet is ranked in the top French and international guides and rankings.

Best Law Firm 2026

Jeantet is among the distinguished firms in the inaugural edition of Best Law Firms™ - France 2026.

Best Lawyers

Jeantet has been recognized by Best Lawyers.

IFLR 1000

Jeantet has been recognized by the IFLR 1000 organization as a "Recommended Firm".

Leaders League

Jeantet has been recognized as leading by the ranking organization Leaders League.